{"id":"tp-50576","type":"article-newspaper","title":"Vicore Pharma Posts Q3 Loss of SEK 0.44 Per Share as Revenue Falls 25%","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/50576","datePublished":"2026-11-07T04:35:04.000Z","dateModified":"2026-11-07T04:35:04.000Z","language":"en","abstract":"Net loss widened to SEK 124.3 million, and cash, cash equivalents and short-term investments totaled SEK 772 million at Sept. 30, 2026.","section":"Business","references":[]}